Details for New Drug Application (NDA): 050588
✉ Email this page to a colleague
The generic ingredient in CEFOTAN is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for 050588
Tradename: | CEFOTAN |
Applicant: | Pai Holdings Pharm |
Ingredient: | cefotetan disodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 050588
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 050588 | NDA | PAI Holdings, LLC dba PAI Pharma | 0121-0976 | 0121-0976-10 | 10 VIAL in 1 TRAY (0121-0976-10) / 10 mL in 1 VIAL (0121-0976-55) |
CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 050588 | NDA | PAI Holdings, LLC dba PAI Pharma | 0121-0977 | 0121-0977-10 | 10 VIAL in 1 TRAY (0121-0977-10) / 20 mL in 1 VIAL (0121-0977-55) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 27, 1985 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 27, 1985 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
Approval Date: | Apr 25, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription